SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The Andaman cobra is one of the rarest and least known of all cobra species. It is endemic to the Andaman and Little Andaman ...

Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have received a consensus rating of “Buy” from the thirteen ratings firms that are covering the firm, MarketBeat reports. One analyst ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are covering the company, Ratings reports. Three ...